Atara Biotherapeutics, Inc. (0HIY.L)

USD 5.7

(-7.74%)

Inventory Summary of Atara Biotherapeutics, Inc.

  • Atara Biotherapeutics, Inc.'s latest annual inventory in 2023 was 9.7 Million USD , up 511.98% from previous year.
  • Atara Biotherapeutics, Inc.'s latest quarterly inventory in 2024 Q2 was 18.74 Million USD , up 16.57% from previous quarter.
  • Atara Biotherapeutics, Inc. reported annual inventory of 1.58 Million USD in 2022, up 158599900.0% from previous year.
  • Atara Biotherapeutics, Inc. reported annual inventory of 1.00 USD in 2021, down 0.0% from previous year.
  • Atara Biotherapeutics, Inc. reported quarterly inventory of 16.08 Million USD for 2024 Q1, up 65.71% from previous quarter.
  • Atara Biotherapeutics, Inc. reported quarterly inventory of 5.34 Million USD for 2023 Q1, up 236.7% from previous quarter.

Annual Inventory Chart of Atara Biotherapeutics, Inc. (2023 - 2012)

Historical Annual Inventory of Atara Biotherapeutics, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 9.7 Million USD 511.98%
2022 1.58 Million USD 158599900.0%
2021 1.00 USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Inventory Comparison of Atara Biotherapeutics, Inc.

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD 19.278%
Agios Pharmaceuticals, Inc. 19.07 Million USD 49.119%
Amicus Therapeutics, Inc. 59.69 Million USD 83.741%
bluebird bio, Inc. 22.91 Million USD 57.651%
Cara Therapeutics, Inc. 2.82 Million USD -244.062%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 97.485%
Myriad Genetics, Inc. 20.1 Million USD 51.711%
Neurocrine Biosciences, Inc. 38.3 Million USD 74.658%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 87.461%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.883%
Waters Corporation 516.23 Million USD 98.12%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.809%
Biogen Inc. 2.52 Billion USD 99.616%
Nektar Therapeutics 16.1 Million USD 39.718%
Perrigo Company plc 1.14 Billion USD 99.149%
Dynavax Technologies Corporation 53.29 Million USD 81.786%
Illumina, Inc. 587 Million USD 98.347%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD 6.421%
Heron Therapeutics, Inc. 42.11 Million USD 76.951%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 99.123%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD 11.748%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 99.624%
Esperion Therapeutics, Inc. 65.62 Million USD 85.209%
FibroGen, Inc. 41.56 Million USD 76.649%
Agilent Technologies, Inc. 1.03 Billion USD 99.059%
OPKO Health, Inc. 65.69 Million USD 85.226%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 89.112%
Exelixis, Inc. 17.32 Million USD 43.97%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 99.621%
Axsome Therapeutics, Inc. 15.13 Million USD 35.87%
Abeona Therapeutics Inc. -2.44 Million USD 497.136%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 98.686%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 65.854%
Sarepta Therapeutics, Inc. 322.85 Million USD 96.994%
Corcept Therapeutics Incorporated 7.73 Million USD -25.563%
Halozyme Therapeutics, Inc. 127.6 Million USD 92.393%
Blueprint Medicines Corporation 21.22 Million USD 54.267%
Insmed Incorporated 83.24 Million USD 88.341%
TG Therapeutics, Inc. 39.82 Million USD 75.627%
Incyte Corporation 62.97 Million USD 84.587%
Emergent BioSolutions Inc. 328.9 Million USD 97.049%